Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 1993-06-04 (32 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CASTELNAU-DE-LEVIS (81150), Tarn
PHARMACIE DE LA TOUR : revenue, balance sheet and financial ratios
PHARMACIE DE LA TOUR is a French company
founded 32 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CASTELNAU-DE-LEVIS (81150),
this company of category PME
shows in 2023 a revenue of 1.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA TOUR (SIREN 391392925)
Indicator
2024
2023
2022
2017
2016
Revenue
N/C
1 226 271 €
894 587 €
978 119 €
1 004 137 €
Net income
137 400 €
125 025 €
15 222 €
16 125 €
21 314 €
EBITDA
N/C
161 827 €
17 677 €
27 268 €
36 249 €
Net margin
N/C
10.2%
1.7%
1.6%
2.1%
Revenue and income statement
In 2024, PHARMACIE DE LA TOUR generates positive net income of 137 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 21 k€ -> 137 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
137 400 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.07%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
65.08%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA TOUR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2022
2023
2024
Debt ratio
152.713
112.942
0.0
0.0
0.07
Financial autonomy
27.72
28.717
48.079
63.478
65.08
Repayment capacity
5.404
5.07
0.0
0.0
None
Cash flow / Revenue
2.476%
2.098%
2.141%
10.547%
None%
Sector positioning
Debt ratio
0.072024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of PHARMACIE DE LA TOUR (0.07) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
65.08%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+18 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE LA TOUR (65.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.0 years2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DE LA TOUR (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 276.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
276.841
Liquidity indicators evolution PHARMACIE DE LA TOUR
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2022
2023
2024
Liquidity ratio
190.348
150.686
181.0
261.103
276.841
Interest coverage
2.99
2.816
0.079
0.373
None
Sector positioning
Liquidity ratio
276.842024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent+34 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LA TOUR (276.84) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.37x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DE LA TOUR (0.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA TOUR
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2022
2023
2024
Operating WCR
98 797 €
93 890 €
64 974 €
169 765 €
0 €
Inventory turnover (days)
37
39
37
34
0
Customer payment term (days)
0
0
1
9
0
Supplier payment term (days)
32
46
49
43
0
Positioning of PHARMACIE DE LA TOUR in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA TOUR is estimated at
1 918 205 €
(range 1 335 808€ - 2 869 745€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1335k€1918k€2869k€
1 918 205 €Range: 1 335 808€ - 2 869 745€
NAF 5 année 2024
Valuation method used
Net Income Multiple
137 400 €
×
14.0x
=1 918 206 €
Range: 1 335 808€ - 2 869 745€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA TOUR with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA TOUR
What is the revenue of PHARMACIE DE LA TOUR ?
The revenue of PHARMACIE DE LA TOUR in 2023 is 1.2 M€.
Is PHARMACIE DE LA TOUR profitable?
Yes, PHARMACIE DE LA TOUR generated a net profit of 137 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA TOUR ?
The headquarters of PHARMACIE DE LA TOUR is located in CASTELNAU-DE-LEVIS (81150), in the department Tarn.
Where to find the tax return of PHARMACIE DE LA TOUR ?
The tax return of PHARMACIE DE LA TOUR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA TOUR operate?
PHARMACIE DE LA TOUR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart